A Novel Retatrutide: A GLP & GIP Receptor Agonist

Showing promise in the field of weight management therapy, retatrutide is a different approach. Beyond many current medications, retatrutide works as a twin agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) sensors. This simultaneous engagement promotes various beneficial effects, inclu

read more